(Q40184040)
Statements
Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases (English)
Ragini Vittal
Hengmin Zhang
Victor J Thannickal
11 January 2007